Gary S Jacob's Net Worth
-$683 Thousand
Who is Gary S Jacob?
Gary S Jacob does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Synergy Pharmaceuticals, Inc., Virpax Pharmaceuticals, Inc., Hepion Pharmaceuticals, Inc., Cardiff Oncology, Inc., OKYO Pharma Ltd, and CALLISTO PHARMACEUTICALS INC.
SEC CIK
Gary S Jacob's CIK is 0001266802
Past Insider Trading and Trends
2013 was Gary S Jacob's most active year for acquiring shares with 16 total transactions. Gary S Jacob's most active month to acquire stocks was the month of December. 2013 was Gary S Jacob's most active year for disposing of shares, totalling 8 transactions. Gary S Jacob's most active month to dispose stocks was the month of December. 2018 saw Gary S Jacob paying a total of $8,877,480.50 for 1,504,590 shares, this is the most they've acquired in one year. In 2017 Gary S Jacob cashed out on 909,287 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Synergy Pharmaceuticals, Inc. No price found
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +47.87% | 192.78K |
$0.50 | $237,480.50 | 595.46K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
| +1.43% | 5.68K |
$3.52 | $19,967.47 | 402.68K |
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
| +18.85% | 62.97K |
$5.61 | $353,233.65 | 397K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +1.20% | 4K |
$4.18 | $16,720.00 | 338.03K |
May 27
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4/A
| +9.19% | 26.49K |
—
|
—
| 314.79K |
Jan 17
| |||
Form 4
| -7.76% | -26.49K |
—
|
—
| 314.79K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Virpax Pharmaceuticals, Inc. (VRPX) Snapshot price: $0.3632
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 7
| |||
Form 4
|
∞
| 3.5K |
$6.79 | $23,761.50 | 3.5K |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Hepion Pharmaceuticals, Inc. (HEPA) Snapshot price: $1.55
CEO and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +20,338.98% | 12K |
$1.66 | $19,920.00 | 12.06K |
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
|
∞
| 32.94K |
—
|
—
| 32.94K |
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cardiff Oncology, Inc. (CRDF) Snapshot price: $1.86
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +12.12% | 2.37K |
$10.42 | $24,689.35 | 21.92K |
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +845.00% | 17.48K |
$1.43 | $25,000.69 | 19.55K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +12.60% | 16.67K |
—
|
—
| 148.95K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
| +7.55% | 9.29K |
—
|
—
| 132.29K |
Sep 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OKYO Pharma Ltd (OKYO) Snapshot price: $1.32
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.5K |
$4.00 | $50,000.00 | 12.5K |
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||